Cargando…

Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial

OBJECTIVE: Epilepsy develops in 70 to 90% of children with tuberous sclerosis complex (TSC) and is often resistant to medication. Recently, the concept of preventive antiepileptic treatment to modify the natural history of epilepsy has been proposed. EPISTOP was a clinical trial designed to compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotulska, Katarzyna, Kwiatkowski, David J., Curatolo, Paolo, Weschke, Bernhard, Riney, Kate, Jansen, Floor, Feucht, Martha, Krsek, Pavel, Nabbout, Rima, Jansen, Anna C., Wojdan, Konrad, Sijko, Kamil, Głowacka‐Walas, Jagoda, Borkowska, Julita, Sadowski, Krzysztof, Domańska‐Pakieła, Dorota, Moavero, Romina, Hertzberg, Christoph, Hulshof, Hanna, Scholl, Theresa, Benova, Barbora, Aronica, Eleonora, de Ridder, Jessie, Lagae, Lieven, Jóźwiak, Sergiusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898885/ https://www.ncbi.nlm.nih.gov/pubmed/33180985 http://dx.doi.org/10.1002/ana.25956

Ejemplares similares

Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study
por: Moavero, Romina, et al.
Publicado: (2019)

Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years
por: Huschner, Franz, et al.
Publicado: (2023)

Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?
por: Moavero, Romina, et al.
Publicado: (2020)

Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics
por: De Ridder, Jessie, et al.
Publicado: (2020)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
por: Sadowski, Krzysztof, et al.
Publicado: (2022)

miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex
por: Scheper, Mirte, et al.
Publicado: (2022)

Epilepsy and Language Development in 8–36-Month-Old Toddlers with Tuberous Sclerosis Complex
por: Foryś-Basiejko, Małgorzata, et al.
Publicado: (2022)

Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers
por: Mühlebner, Angelika, et al.
Publicado: (2020)

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
por: Kotulska, Katarzyna, et al.
Publicado: (2014)

The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia
por: Hulshof, Hanna M., et al.
Publicado: (2021)

Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
por: Mills, James D., et al.
Publicado: (2017)

Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period
por: Korotkov, Anatoly, et al.
Publicado: (2022)

Author Correction: Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment
por: Mills, James D., et al.
Publicado: (2022)

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

MicroRNA‐34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis
por: Korotkov, Anatoly, et al.
Publicado: (2021)

Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?
por: Słowińska, Monika, et al.
Publicado: (2018)

Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries
por: Jurkiewicz, Elzbieta, et al.
Publicado: (2015)

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex
por: Mühlebner, Angelika, et al.
Publicado: (2016)

Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC)
por: Fuso, A., et al.
Publicado: (2016)

Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase
por: Malik, Anna R., et al.
Publicado: (2015)

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro
por: Bongaarts, Anika, et al.
Publicado: (2020)

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Psychometric properties of the Czech version of the Stigma Scale of Epilepsy
por: Brabcová, Dana, et al.
Publicado: (2018)

PPFIA4 mutation: A second hit in POLG related disease?
por: Sourbron, Jo, et al.
Publicado: (2021)

The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas
por: Bongaarts, Anika, et al.
Publicado: (2020)

A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report
por: Auvin, Stéphane, et al.
Publicado: (2019)

Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression
por: Mühlebner, Angelika, et al.
Publicado: (2016)

TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex
por: Kingswood, John C, et al.
Publicado: (2014)

Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study
por: Jansen, Anna C., et al.
Publicado: (2019)

Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project
por: de Vries, Petrus J., et al.
Publicado: (2020)

Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry
por: Nabbout, Rima, et al.
Publicado: (2021)

Influence of Dietary Compounds on Arsenic Metabolism and Toxicity. Part I—Animal Model Studies
por: Sijko, Monika, et al.
Publicado: (2021)

Influence of Dietary Compounds on Arsenic Metabolism and Toxicity. Part II—Human Studies
por: Sijko, Monika, et al.
Publicado: (2021)

Successful Prenatal Treatment of Cardiac Rhabdomyoma in a Fetus with Tuberous Sclerosis
por: Will, Joachim Carsten, et al.
Publicado: (2023)

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study
por: Bobeff, Katarzyna, et al.
Publicado: (2021)

Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex—Current Views on Their Pathogenesis and Management
por: Gao, Chao, et al.
Publicado: (2023)

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
por: Gao, Chao, et al.
Publicado: (2023)

TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients
por: Kingswood, John C., et al.
Publicado: (2017)

TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study
por: de Vries, Petrus J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7p4qfeomaalfb1ftj8fvt4ovi0